JP5355098B2 - 着用可能な腎臓 - Google Patents
着用可能な腎臓 Download PDFInfo
- Publication number
- JP5355098B2 JP5355098B2 JP2008558369A JP2008558369A JP5355098B2 JP 5355098 B2 JP5355098 B2 JP 5355098B2 JP 2008558369 A JP2008558369 A JP 2008558369A JP 2008558369 A JP2008558369 A JP 2008558369A JP 5355098 B2 JP5355098 B2 JP 5355098B2
- Authority
- JP
- Japan
- Prior art keywords
- peritoneal dialysis
- wearable
- patient
- dialysis system
- dialysis solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000003734 kidney Anatomy 0.000 title description 5
- 238000000502 dialysis Methods 0.000 claims abstract description 133
- 239000000385 dialysis solution Substances 0.000 claims abstract description 133
- 150000002500 ions Chemical class 0.000 claims abstract description 64
- 108090000790 Enzymes Proteins 0.000 claims abstract description 61
- 102000004190 Enzymes Human genes 0.000 claims abstract description 61
- 239000002207 metabolite Substances 0.000 claims abstract description 52
- 239000002699 waste material Substances 0.000 claims abstract description 52
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 104
- 239000004202 carbamide Substances 0.000 claims description 101
- 239000012530 fluid Substances 0.000 claims description 58
- 239000012528 membrane Substances 0.000 claims description 54
- 239000003463 adsorbent Substances 0.000 claims description 46
- 239000012510 hollow fiber Substances 0.000 claims description 42
- 239000002253 acid Substances 0.000 claims description 41
- 239000000463 material Substances 0.000 claims description 34
- 238000005342 ion exchange Methods 0.000 claims description 32
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 31
- 108010046334 Urease Proteins 0.000 claims description 29
- 239000003729 cation exchange resin Substances 0.000 claims description 23
- 239000000203 mixture Substances 0.000 claims description 21
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 20
- 229910019142 PO4 Inorganic materials 0.000 claims description 20
- 239000011575 calcium Substances 0.000 claims description 20
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 19
- 239000010452 phosphate Substances 0.000 claims description 19
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 16
- 229910052791 calcium Inorganic materials 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 14
- 238000001728 nano-filtration Methods 0.000 claims description 14
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 13
- 239000011777 magnesium Substances 0.000 claims description 13
- 229910052749 magnesium Inorganic materials 0.000 claims description 13
- 238000000746 purification Methods 0.000 claims description 12
- 210000004027 cell Anatomy 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 10
- 239000003957 anion exchange resin Substances 0.000 claims description 9
- 238000005341 cation exchange Methods 0.000 claims description 9
- 230000009977 dual effect Effects 0.000 claims description 9
- 230000003604 ureolytic effect Effects 0.000 claims description 9
- 229920002301 cellulose acetate Polymers 0.000 claims description 8
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims description 7
- 229910001424 calcium ion Inorganic materials 0.000 claims description 7
- 229910001385 heavy metal Inorganic materials 0.000 claims description 7
- 229910001425 magnesium ion Inorganic materials 0.000 claims description 7
- 239000007800 oxidant agent Substances 0.000 claims description 7
- 230000001580 bacterial effect Effects 0.000 claims description 6
- 229910000166 zirconium phosphate Inorganic materials 0.000 claims description 6
- LEHFSLREWWMLPU-UHFFFAOYSA-B zirconium(4+);tetraphosphate Chemical group [Zr+4].[Zr+4].[Zr+4].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O LEHFSLREWWMLPU-UHFFFAOYSA-B 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 108010066906 Creatininase Proteins 0.000 claims description 3
- 108010092464 Urate Oxidase Proteins 0.000 claims description 3
- 210000004962 mammalian cell Anatomy 0.000 claims description 3
- 238000004891 communication Methods 0.000 claims description 2
- 239000000356 contaminant Substances 0.000 claims description 2
- 230000008878 coupling Effects 0.000 claims description 2
- 238000010168 coupling process Methods 0.000 claims description 2
- 238000005859 coupling reaction Methods 0.000 claims description 2
- 210000005253 yeast cell Anatomy 0.000 claims description 2
- 238000005349 anion exchange Methods 0.000 claims 6
- 210000003200 peritoneal cavity Anatomy 0.000 claims 5
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims 2
- 210000003000 inclusion body Anatomy 0.000 claims 2
- 230000000813 microbial effect Effects 0.000 claims 1
- 230000001172 regenerating effect Effects 0.000 claims 1
- 238000001179 sorption measurement Methods 0.000 claims 1
- 239000000243 solution Substances 0.000 abstract description 26
- 238000000034 method Methods 0.000 abstract description 14
- 239000003053 toxin Substances 0.000 abstract description 7
- 231100000765 toxin Toxicity 0.000 abstract description 7
- 108700012359 toxins Proteins 0.000 abstract description 7
- 235000013877 carbamide Nutrition 0.000 description 94
- 150000001768 cations Chemical class 0.000 description 48
- 210000004379 membrane Anatomy 0.000 description 45
- 239000011347 resin Substances 0.000 description 45
- 229920005989 resin Polymers 0.000 description 45
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 20
- 235000021317 phosphate Nutrition 0.000 description 18
- 239000003456 ion exchange resin Substances 0.000 description 16
- 229920003303 ion-exchange polymer Polymers 0.000 description 16
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 14
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 13
- 230000003187 abdominal effect Effects 0.000 description 11
- 239000002441 uremic toxin Substances 0.000 description 11
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 10
- 239000011734 sodium Substances 0.000 description 10
- 229910052708 sodium Inorganic materials 0.000 description 10
- -1 ammonium ions Chemical class 0.000 description 9
- 238000005538 encapsulation Methods 0.000 description 9
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 8
- 239000007857 degradation product Substances 0.000 description 8
- 238000001631 haemodialysis Methods 0.000 description 8
- 230000000322 hemodialysis Effects 0.000 description 8
- 230000003204 osmotic effect Effects 0.000 description 8
- 210000004303 peritoneum Anatomy 0.000 description 8
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 8
- 239000011591 potassium Substances 0.000 description 8
- 229910052700 potassium Inorganic materials 0.000 description 8
- 229910021529 ammonia Inorganic materials 0.000 description 7
- 229940109239 creatinine Drugs 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 238000004064 recycling Methods 0.000 description 7
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 6
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 229940023913 cation exchange resins Drugs 0.000 description 6
- 230000000593 degrading effect Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000001257 hydrogen Substances 0.000 description 6
- 229910052739 hydrogen Inorganic materials 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 229940116269 uric acid Drugs 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 210000001015 abdomen Anatomy 0.000 description 5
- 238000000354 decomposition reaction Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 239000012535 impurity Substances 0.000 description 5
- 239000003014 ion exchange membrane Substances 0.000 description 5
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 230000008085 renal dysfunction Effects 0.000 description 5
- 230000000717 retained effect Effects 0.000 description 5
- 229910001928 zirconium oxide Inorganic materials 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 208000001647 Renal Insufficiency Diseases 0.000 description 4
- 150000001450 anions Chemical class 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 201000006370 kidney failure Diseases 0.000 description 4
- 239000002357 osmotic agent Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 239000003011 anion exchange membrane Substances 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920001429 chelating resin Polymers 0.000 description 3
- 208000020832 chronic kidney disease Diseases 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 239000008393 encapsulating agent Substances 0.000 description 3
- 230000007717 exclusion Effects 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 208000017169 kidney disease Diseases 0.000 description 3
- 230000003907 kidney function Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 238000005086 pumping Methods 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000000108 ultra-filtration Methods 0.000 description 3
- 229940045136 urea Drugs 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- 229920001747 Cellulose diacetate Polymers 0.000 description 2
- 229920002284 Cellulose triacetate Polymers 0.000 description 2
- QDHHCQZDFGDHMP-UHFFFAOYSA-N Chloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 229920002518 Polyallylamine hydrochloride Polymers 0.000 description 2
- 239000004695 Polyether sulfone Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000001099 ammonium carbonate Substances 0.000 description 2
- 235000012501 ammonium carbonate Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 102000015736 beta 2-Microglobulin Human genes 0.000 description 2
- 108010081355 beta 2-Microglobulin Proteins 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 208000028208 end stage renal disease Diseases 0.000 description 2
- 201000000523 end stage renal failure Diseases 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- 239000003330 peritoneal dialysis fluid Substances 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 229920002492 poly(sulfone) Polymers 0.000 description 2
- 229920000768 polyamine Polymers 0.000 description 2
- 229920006393 polyether sulfone Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 229940020428 renagel Drugs 0.000 description 2
- ZNSIZMQNQCNRBW-UHFFFAOYSA-N sevelamer Chemical compound NCC=C.ClCC1CO1 ZNSIZMQNQCNRBW-UHFFFAOYSA-N 0.000 description 2
- 239000002594 sorbent Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- QWFMDSOYEQHWMF-UHFFFAOYSA-N 2,3-bis(ethenyl)benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC(C=C)=C1C=C QWFMDSOYEQHWMF-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 244000045232 Canavalia ensiformis Species 0.000 description 1
- 235000010520 Canavalia ensiformis Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical group [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- KHNXRSIBRKBJDI-UHFFFAOYSA-N Sevelamer hydrochloride Chemical compound Cl.NCC=C.ClCC1CO1 KHNXRSIBRKBJDI-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000002801 charged material Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007485 conventional hemodialysis Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- OEBRKCOSUFCWJD-UHFFFAOYSA-N dichlorvos Chemical compound COP(=O)(OC)OC=C(Cl)Cl OEBRKCOSUFCWJD-UHFFFAOYSA-N 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- IBIRZFNPWYRWOG-UHFFFAOYSA-N phosphane;phosphoric acid Chemical compound P.OP(O)(O)=O IBIRZFNPWYRWOG-UHFFFAOYSA-N 0.000 description 1
- 239000002694 phosphate binding agent Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 231100000683 possible toxicity Toxicity 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 230000003134 recirculating effect Effects 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000013878 renal filtration Effects 0.000 description 1
- 239000012508 resin bead Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229960003027 sevelamer hydrochloride Drugs 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229910052716 thallium Inorganic materials 0.000 description 1
- BKVIYDNLLOSFOA-UHFFFAOYSA-N thallium Chemical compound [Tl] BKVIYDNLLOSFOA-UHFFFAOYSA-N 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 239000010891 toxic waste Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
- XJUNLJFOHNHSAR-UHFFFAOYSA-J zirconium(4+);dicarbonate Chemical compound [Zr+4].[O-]C([O-])=O.[O-]C([O-])=O XJUNLJFOHNHSAR-UHFFFAOYSA-J 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1694—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes with recirculating dialysing liquid
- A61M1/1696—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes with recirculating dialysing liquid with dialysate regeneration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
- A61M1/282—Operational modes
- A61M1/284—Continuous flow peritoneal dialysis [CFPD]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2209/00—Ancillary equipment
- A61M2209/08—Supports for equipment
- A61M2209/088—Supports for equipment on the body
Landscapes
- Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- External Artificial Organs (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Treatment Of Water By Ion Exchange (AREA)
- Water Treatment By Sorption (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/371,216 US8715221B2 (en) | 2006-03-08 | 2006-03-08 | Wearable kidney |
| US11/371,216 | 2006-03-08 | ||
| PCT/US2007/005779 WO2007103411A2 (en) | 2006-03-08 | 2007-03-08 | Wearable kidney |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009528897A JP2009528897A (ja) | 2009-08-13 |
| JP2009528897A5 JP2009528897A5 (enExample) | 2010-04-15 |
| JP5355098B2 true JP5355098B2 (ja) | 2013-11-27 |
Family
ID=38420619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008558369A Expired - Fee Related JP5355098B2 (ja) | 2006-03-08 | 2007-03-08 | 着用可能な腎臓 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8715221B2 (enExample) |
| EP (1) | EP1991289B1 (enExample) |
| JP (1) | JP5355098B2 (enExample) |
| KR (1) | KR101333775B1 (enExample) |
| CN (1) | CN101394876B (enExample) |
| AU (2) | AU2007223935B2 (enExample) |
| CA (1) | CA2644579C (enExample) |
| WO (1) | WO2007103411A2 (enExample) |
Families Citing this family (116)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8715221B2 (en) | 2006-03-08 | 2014-05-06 | Fresenius Medical Care Holdings, Inc. | Wearable kidney |
| US8012118B2 (en) * | 2006-03-08 | 2011-09-06 | Fresenius Medical Care Holdings, Inc. | Artificial kidney dialysis system |
| AU2007288199B2 (en) | 2006-08-24 | 2010-08-26 | Fresenius Medical Care Holdings, Inc. | Device for removing fluid from blood in a patient |
| DE102008003090A1 (de) | 2008-01-03 | 2009-07-16 | Fresenius Medical Care Deutschland Gmbh | Hohlfasermembran |
| US8349813B2 (en) * | 2008-03-20 | 2013-01-08 | Baxter International Inc. | Destruction of microbial products by enzymatic digestion |
| US20090236284A1 (en) * | 2008-03-20 | 2009-09-24 | Baxter International Inc. | Removal of substances in dialysis solutions and dialysis components by ion exchange adsorption |
| AU2009263046B2 (en) * | 2008-06-23 | 2014-07-24 | Temasek Polytechnic | A flow system of a dialysis device and a portable dialysis device |
| US9821105B2 (en) | 2008-07-01 | 2017-11-21 | Baxter International Inc. | Nanoclay sorbents for dialysis |
| US8349174B2 (en) * | 2008-07-23 | 2013-01-08 | Baxter International Inc. | Portable power dialysis machine |
| CN102202702B (zh) * | 2008-11-03 | 2014-05-21 | 弗雷泽纽斯医疗保健控股有限公司 | 便携式腹膜透析系统 |
| US8080161B2 (en) | 2009-06-11 | 2011-12-20 | Baxter International Inc. | Dialysis treatment devices for removing urea |
| US8404091B2 (en) * | 2009-08-27 | 2013-03-26 | Baxter International Inc. | Dialysis treatment devices for removing urea |
| CA2772629C (en) * | 2009-09-08 | 2018-02-27 | Fresenius Medical Care Holdings, Inc. | Peritoneal dialysis system |
| US9475709B2 (en) | 2010-08-25 | 2016-10-25 | Lockheed Martin Corporation | Perforated graphene deionization or desalination |
| EP3536361B1 (en) | 2011-03-23 | 2020-10-07 | NxStage Medical Inc. | Peritoneal dialysis systems, devices, and methods |
| US9861733B2 (en) | 2012-03-23 | 2018-01-09 | Nxstage Medical Inc. | Peritoneal dialysis systems, devices, and methods |
| JP5846754B2 (ja) * | 2011-03-31 | 2016-01-20 | Ｄｏｗａエコシステム株式会社 | フッ素イオン処理装置及びフッ素イオン処理方法 |
| US9517424B2 (en) | 2011-04-14 | 2016-12-13 | University Of Florida Research Foundation, Inc | Method for removing hydrogen phosphate from an aqueous solution using alpha zirconium phosphate |
| MX339595B (es) * | 2011-07-29 | 2016-06-01 | Baxter Int | Manejo de sodio para sistemas de dialisis. |
| CN103889481B (zh) | 2011-08-02 | 2016-03-09 | 美敦力公司 | 带有具有可控的顺应性容积的流动路径的血液透析系统 |
| JP5838645B2 (ja) * | 2011-08-09 | 2016-01-06 | 三菱レイヨンアクア・ソリューションズ株式会社 | 超純水の製造方法 |
| US10857277B2 (en) | 2011-08-16 | 2020-12-08 | Medtronic, Inc. | Modular hemodialysis system |
| WO2013025957A1 (en) | 2011-08-18 | 2013-02-21 | Fresenius Medical Care Holdings, Inc. | Sorbent and chemical regeneration of dialysate |
| CN103842004B (zh) | 2011-08-22 | 2016-11-23 | 美敦力公司 | 双流吸附剂盒 |
| US9616163B2 (en) * | 2012-01-04 | 2017-04-11 | Fresenius Medical Care Holdings, Inc. | Method and system of enhancing removal of toxic anions and organic solutes in sorbent dialysis |
| US9713668B2 (en) | 2012-01-04 | 2017-07-25 | Medtronic, Inc. | Multi-staged filtration system for blood fluid removal |
| US10653824B2 (en) | 2012-05-25 | 2020-05-19 | Lockheed Martin Corporation | Two-dimensional materials and uses thereof |
| US10213746B2 (en) | 2016-04-14 | 2019-02-26 | Lockheed Martin Corporation | Selective interfacial mitigation of graphene defects |
| US10980919B2 (en) | 2016-04-14 | 2021-04-20 | Lockheed Martin Corporation | Methods for in vivo and in vitro use of graphene and other two-dimensional materials |
| US9744617B2 (en) | 2014-01-31 | 2017-08-29 | Lockheed Martin Corporation | Methods for perforating multi-layer graphene through ion bombardment |
| US9610546B2 (en) | 2014-03-12 | 2017-04-04 | Lockheed Martin Corporation | Separation membranes formed from perforated graphene and methods for use thereof |
| US9834809B2 (en) | 2014-02-28 | 2017-12-05 | Lockheed Martin Corporation | Syringe for obtaining nano-sized materials for selective assays and related methods of use |
| US10905816B2 (en) | 2012-12-10 | 2021-02-02 | Medtronic, Inc. | Sodium management system for hemodialysis |
| US11565029B2 (en) | 2013-01-09 | 2023-01-31 | Medtronic, Inc. | Sorbent cartridge with electrodes |
| US9707328B2 (en) | 2013-01-09 | 2017-07-18 | Medtronic, Inc. | Sorbent cartridge to measure solute concentrations |
| US11154648B2 (en) | 2013-01-09 | 2021-10-26 | Medtronic, Inc. | Fluid circuits for sorbent cartridge with sensors |
| US9713666B2 (en) | 2013-01-09 | 2017-07-25 | Medtronic, Inc. | Recirculating dialysate fluid circuit for blood measurement |
| US9623164B2 (en) | 2013-02-01 | 2017-04-18 | Medtronic, Inc. | Systems and methods for multifunctional volumetric fluid control |
| US10850016B2 (en) | 2013-02-01 | 2020-12-01 | Medtronic, Inc. | Modular fluid therapy system having jumpered flow paths and systems and methods for cleaning and disinfection |
| US10543052B2 (en) | 2013-02-01 | 2020-01-28 | Medtronic, Inc. | Portable dialysis cabinet |
| US10010663B2 (en) | 2013-02-01 | 2018-07-03 | Medtronic, Inc. | Fluid circuit for delivery of renal replacement therapies |
| US9144640B2 (en) | 2013-02-02 | 2015-09-29 | Medtronic, Inc. | Sorbent cartridge configurations for improved dialysate regeneration |
| US9827361B2 (en) | 2013-02-02 | 2017-11-28 | Medtronic, Inc. | pH buffer measurement system for hemodialysis systems |
| US9592475B2 (en) | 2013-03-12 | 2017-03-14 | Lockheed Martin Corporation | Method for forming perforated graphene with uniform aperture size |
| US20140263062A1 (en) | 2013-03-14 | 2014-09-18 | Fresenius Medical Care Holdings, Inc. | Universal portable machine for online hemodiafiltration using regenerated dialysate |
| US9433720B2 (en) | 2013-03-14 | 2016-09-06 | Fresenius Medical Care Holdings, Inc. | Universal portable artificial kidney for hemodialysis and peritoneal dialysis |
| US9572918B2 (en) | 2013-06-21 | 2017-02-21 | Lockheed Martin Corporation | Graphene-based filter for isolating a substance from blood |
| WO2015029936A1 (ja) * | 2013-08-26 | 2015-03-05 | 独立行政法人物質・材料研究機構 | 血液浄化用膜、血液浄化用膜の製造方法及び透析装置 |
| US9707329B2 (en) * | 2013-10-23 | 2017-07-18 | Fresenius Medical Care Holdings, Inc. | Process for regeneration of spent zirconium phosphate for reuse in sorbent treatments |
| US10537875B2 (en) | 2013-11-26 | 2020-01-21 | Medtronic, Inc. | Precision recharging of sorbent materials using patient and session data |
| US9974896B2 (en) * | 2014-06-24 | 2018-05-22 | Medtronic, Inc. | Method of zirconium phosphate recharging |
| US10052612B2 (en) | 2013-11-26 | 2018-08-21 | Medtronic, Inc. | Zirconium phosphate recharging method and apparatus |
| US9895477B2 (en) | 2013-11-26 | 2018-02-20 | Medtronic, Inc. | Detachable module for recharging sorbent materials with optional bypass |
| US9943780B2 (en) | 2013-11-26 | 2018-04-17 | Medtronic, Inc. | Module for in-line recharging of sorbent materials with optional bypass |
| US10004839B2 (en) | 2013-11-26 | 2018-06-26 | Medtronic, Inc. | Multi-use sorbent cartridge |
| US9884145B2 (en) | 2013-11-26 | 2018-02-06 | Medtronic, Inc. | Parallel modules for in-line recharging of sorbents using alternate duty cycles |
| JP2017507044A (ja) | 2014-01-31 | 2017-03-16 | ロッキード マーティン コーポレイションＬｏｃｋｈｅｅｄ Ｍａｒｔｉｎ Ｃｏｒｐｏｒａｔｉｏｎ | 多孔性非犠牲支持層を用いた二次元材料とのコンポジット構造を形成するための方法 |
| WO2015116946A1 (en) | 2014-01-31 | 2015-08-06 | Lockheed Martin Corporation | Perforating two-dimensional materials using broad ion field |
| JP2017512129A (ja) | 2014-03-12 | 2017-05-18 | ロッキード・マーチン・コーポレーション | 有孔グラフェンから形成された分離膜 |
| US10016553B2 (en) | 2014-06-24 | 2018-07-10 | Medtronic, Inc. | Replenishing urease in dialysis systems using a urease introducer |
| CN106604752B (zh) * | 2014-06-24 | 2019-07-09 | 美敦力公司 | 用于补充吸附剂盒内的脲酶的脲酶引入系统 |
| WO2015199761A1 (en) | 2014-06-24 | 2015-12-30 | Medtronic, Inc. | Sorbent pouch |
| WO2015199764A1 (en) | 2014-06-24 | 2015-12-30 | Medtronic, Inc. | Replenishing urease in dialysis systems using urease pouches |
| US10357757B2 (en) | 2014-06-24 | 2019-07-23 | Medtronic, Inc. | Stacked sorbent assembly |
| US10172991B2 (en) | 2014-06-24 | 2019-01-08 | Medtronic, Inc. | Modular dialysate regeneration assembly |
| CN107073408A (zh) | 2014-09-02 | 2017-08-18 | 洛克希德马丁公司 | 基于二维膜材料的血液透析膜和血液过滤膜及其应用方法 |
| US10874787B2 (en) | 2014-12-10 | 2020-12-29 | Medtronic, Inc. | Degassing system for dialysis |
| US9713665B2 (en) | 2014-12-10 | 2017-07-25 | Medtronic, Inc. | Degassing system for dialysis |
| US9895479B2 (en) | 2014-12-10 | 2018-02-20 | Medtronic, Inc. | Water management system for use in dialysis |
| US10098993B2 (en) | 2014-12-10 | 2018-10-16 | Medtronic, Inc. | Sensing and storage system for fluid balance |
| US11040172B2 (en) | 2015-07-20 | 2021-06-22 | Strataca Systems Limited | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
| BR112018001110B1 (pt) | 2015-07-20 | 2023-04-18 | Roivios Limited | Cateter uretral e sistema para induzir pressão negativa em uma porção de um trato urinário de um paciente |
| US12064567B2 (en) | 2015-07-20 | 2024-08-20 | Roivios Limited | Percutaneous urinary catheter |
| US10926062B2 (en) | 2015-07-20 | 2021-02-23 | Strataca Systems Limited | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
| US10493232B2 (en) | 2015-07-20 | 2019-12-03 | Strataca Systems Limited | Ureteral catheters, bladder catheters, systems, kits and methods for inducing negative pressure to increase renal function |
| CA2994549A1 (en) | 2015-08-05 | 2017-02-09 | Lockheed Martin Corporation | Perforatable sheets of graphene-based material |
| CA2994664A1 (en) | 2015-08-06 | 2017-02-09 | Lockheed Martin Corporation | Nanoparticle modification and perforation of graphene |
| SE539744C2 (en) * | 2015-08-27 | 2017-11-14 | Triomed Ab | PERFORMING PERITONEAL ULTRAFILTRATION APPLIANCE |
| US9962477B2 (en) * | 2015-12-30 | 2018-05-08 | Fresenius Medical Care Holdings, Inc. | Cartridge systems useful in cleaning dialysis solutions |
| WO2017116515A1 (en) | 2015-12-31 | 2017-07-06 | Baxter International Inc. | Methods and apparatuses using urea permselective diffusion through charged membranes |
| US10391222B2 (en) | 2015-12-31 | 2019-08-27 | Baxter International Inc. | Devices for urea electrolysis and methods of using same |
| US10406270B2 (en) | 2015-12-31 | 2019-09-10 | Baxter International Inc. | Devices for urea electrolysis with combination electrodialysis and urea oxidation cell and methods of using same |
| JP2019517909A (ja) | 2016-04-14 | 2019-06-27 | ロッキード・マーチン・コーポレーション | 流路を有する二次元膜構造体 |
| SG11201808961QA (en) | 2016-04-14 | 2018-11-29 | Lockheed Corp | Methods for in situ monitoring and control of defect formation or healing |
| WO2017180135A1 (en) | 2016-04-14 | 2017-10-19 | Lockheed Martin Corporation | Membranes with tunable selectivity |
| KR20190019907A (ko) | 2016-04-14 | 2019-02-27 | 록히드 마틴 코포레이션 | 자유-플로팅 방법을 사용한 대규모 이송을 위한 그래핀 시트 취급 방법 |
| US10456515B2 (en) | 2016-06-06 | 2019-10-29 | The Trustees Of Columbia University In The City Of New York | Wearable ultrafiltration devices methods and systems |
| CN106039446B (zh) * | 2016-07-25 | 2018-10-26 | 北京卫健医网临床医学研究有限公司 | 一种可穿戴腹膜透析便携装置 |
| US10933184B2 (en) * | 2016-09-30 | 2021-03-02 | Us Kidney Research Corporation | Dialysate free artificial kidney device |
| US10981148B2 (en) | 2016-11-29 | 2021-04-20 | Medtronic, Inc. | Zirconium oxide module conditioning |
| AU2017371552B2 (en) * | 2016-12-05 | 2023-06-01 | Awak Technologies Pte Ltd | Sorbent for a dialysis device and dialysis system |
| US11167070B2 (en) | 2017-01-30 | 2021-11-09 | Medtronic, Inc. | Ganged modular recharging system |
| RU2692329C2 (ru) * | 2017-04-21 | 2019-06-24 | Общество с ограниченной ответственностью "ЭСДИАР" | Способ искусственного очищения крови с регенерацией диализирующего раствора в экстракорпоральном контуре и устройство для его осуществления |
| US10960381B2 (en) | 2017-06-15 | 2021-03-30 | Medtronic, Inc. | Zirconium phosphate disinfection recharging and conditioning |
| WO2018237375A1 (en) | 2017-06-24 | 2018-12-27 | Nxstage Medical, Inc. | Peritoneal dialysis fluid preparation and/or treatment devices methods and systems |
| CN107433142B (zh) * | 2017-07-10 | 2018-04-06 | 广州达济医学科技有限公司 | 一种选择滤除白细胞和血小板的过滤介质及其制备方法 |
| CN111263653B (zh) | 2017-08-25 | 2022-06-03 | 罗维奥斯有限公司 | 促进从尿道除尿的排尿泵 |
| US11278654B2 (en) | 2017-12-07 | 2022-03-22 | Medtronic, Inc. | Pneumatic manifold for a dialysis system |
| US11033667B2 (en) | 2018-02-02 | 2021-06-15 | Medtronic, Inc. | Sorbent manifold for a dialysis system |
| US11110215B2 (en) | 2018-02-23 | 2021-09-07 | Medtronic, Inc. | Degasser and vent manifolds for dialysis |
| JP2021516089A (ja) | 2018-02-28 | 2021-07-01 | ネクステージ メディカル インコーポレイテッド | 流体調製および処置装置、方法、およびシステム |
| US12285552B2 (en) | 2018-08-14 | 2025-04-29 | Mozarc Medical Us Llc | Precision dialysis therapy based on sorbent effluent analysis |
| US11213616B2 (en) | 2018-08-24 | 2022-01-04 | Medtronic, Inc. | Recharge solution for zirconium phosphate |
| RU2722831C1 (ru) * | 2019-10-18 | 2020-06-04 | Акционерное общество "Зеленоградский инновационно-технологический центр" | Устройство электрохимического удаления мочевины для носимого аппарата внепочечного очищения крови |
| CN110801546B (zh) * | 2019-11-22 | 2022-06-03 | 常州市第二人民医院 | 一种便携式腹膜透析装置 |
| WO2021211061A1 (en) | 2020-04-13 | 2021-10-21 | Temasek Polytechnic | Dialysate regenerator and system comprising the same |
| US12128165B2 (en) | 2020-04-27 | 2024-10-29 | Mozarc Medical Us Llc | Dual stage degasser |
| US11690940B2 (en) | 2020-11-02 | 2023-07-04 | Fresenius Medical Care Holdings, Inc. | Preserving sorbent devices in dialysis systems |
| US12397093B2 (en) | 2021-05-18 | 2025-08-26 | Mozarc Medical Us Llc | Sorbent cartridge designs |
| US12472301B2 (en) | 2021-08-13 | 2025-11-18 | 3Ive Labs, Llc | Negative pressure therapy system and methods |
| CN113855886B (zh) * | 2021-10-20 | 2024-11-08 | 中国科学技术大学 | 一种无膜透析微流控制芯片 |
| US11944733B2 (en) * | 2021-11-18 | 2024-04-02 | Mozarc Medical Us Llc | Sodium and bicarbonate control |
| CN116115847A (zh) * | 2022-11-16 | 2023-05-16 | 中国船舶集团有限公司第七一六研究所 | 可穿戴式人工肾系统液体平衡控制装置 |
| CN115671426B (zh) * | 2022-11-16 | 2025-06-10 | 东南大学 | 透析液再生系统的脲酶引入装置及方法 |
| CN118976167A (zh) * | 2022-12-09 | 2024-11-19 | 上海心光生物医药有限责任公司 | 腹膜透析设备 |
| WO2024259418A1 (en) * | 2023-06-15 | 2024-12-19 | Arizona Board Of Regents On Behalf Of The Univeristy Of Arizona | Method, system and device for water conservation and dialysate recycling |
Family Cites Families (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US594468A (en) * | 1897-11-30 | Vehicle-tire | ||
| US409477A (en) * | 1889-08-20 | Leonidas c | ||
| US409475A (en) * | 1889-08-20 | James e | ||
| US3825493A (en) * | 1972-09-29 | 1974-07-23 | Hydronautics | Peritoneal artificial kidney |
| US3579441A (en) * | 1968-04-19 | 1971-05-18 | Hydronautics | Blood purification by dual filtration |
| US3707967A (en) * | 1970-10-01 | 1973-01-02 | Tecna Corp | Steady flow regenerative peritoneal dialysis system and method |
| DE2558363A1 (de) | 1975-12-23 | 1977-07-07 | Alvaro Prof Dr Affonso | Membranelement zum selektiven entfernen von stoffen aus menschlichem blut |
| US4094775A (en) * | 1977-02-28 | 1978-06-13 | California Institute Of Technology | Dialysis system |
| PT69258A (en) | 1978-02-27 | 1979-03-01 | Lilly Co Eli | Process for preparing a dialysis composition |
| US4256102A (en) * | 1979-05-14 | 1981-03-17 | Monaco Anthony P | Subcutaneous dialysis system |
| JPS6059010B2 (ja) | 1979-10-02 | 1985-12-23 | 工業技術院長 | マイクロカプセル |
| JPS56141835A (en) * | 1980-04-03 | 1981-11-05 | Honda Motor Co Ltd | Selective adsorbing method, selective adsorbent and selective adsorbing device for urea or the like |
| DE3110128A1 (de) | 1981-03-16 | 1982-09-23 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München | Verfahren und vorrichtung zur entgiftung und regeneration von blut, blutbestandteilen und bei der blutreinigung anfallenden loesungen sowie kit fuer die durchfuehrung des verfahrens |
| EP0064393A3 (en) | 1981-05-04 | 1982-12-29 | Purdue Research Foundation | Sorbent mixture for use in hemodialysis |
| EP0118548A1 (en) | 1982-09-09 | 1984-09-19 | Organon Teknika Corporation | Ammonia scavenger |
| US5026365A (en) * | 1987-04-29 | 1991-06-25 | The University Of Massachusetts | Method and apparatus for therapeutically treating immunological disorders and disease states |
| GB8722854D0 (en) | 1987-09-29 | 1987-11-04 | Hardy S M | Implantable artificial kidney |
| US5409903A (en) * | 1992-02-18 | 1995-04-25 | Urecap Corporation | Method and compositions for the treatment of H. pylori and dermatitis |
| US5549674A (en) * | 1992-03-02 | 1996-08-27 | The Regents Of The University Of Michigan | Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo |
| US5284470A (en) * | 1992-11-02 | 1994-02-08 | Beltz Alex D | Wearable, portable, light-weight artificial kidney |
| US5350357A (en) * | 1993-03-03 | 1994-09-27 | Deka Products Limited Partnership | Peritoneal dialysis systems employing a liquid distribution and pumping cassette that emulates gravity flow |
| AU2658195A (en) | 1994-05-31 | 1995-12-21 | Penn State Research Foundation, The | Immobilization of biologically active materials and diagnostic agents in cross-linked poly(organophosphazenes) |
| US5944684A (en) * | 1995-08-31 | 1999-08-31 | The Regents Of The University Of California | Wearable peritoneum-based system for continuous renal function replacement and other biomedical applications |
| GB9601333D0 (en) * | 1996-01-23 | 1996-03-27 | Univ Mcgill | Microencapsulated genetically engineered microorganisms for clinical application |
| AU725693B2 (en) | 1996-03-12 | 2000-10-19 | Board Of Regents Of The University Of Nebraska, The | Targeted site specific drug delivery compositions and method of use |
| US5849727A (en) | 1996-06-28 | 1998-12-15 | Board Of Regents Of The University Of Nebraska | Compositions and methods for altering the biodistribution of biological agents |
| US5902336A (en) * | 1996-10-15 | 1999-05-11 | Mirimedical, Inc. | Implantable device and method for removing fluids from the blood of a patient method for implanting such a device and method for treating a patient experiencing renal failure |
| US5980481A (en) * | 1997-05-08 | 1999-11-09 | Transvivo, Inc. | Method and apparatus for continuous peritoneal cascade dialysis and hemofiltration (CPCD/H) |
| US6254567B1 (en) * | 1999-02-26 | 2001-07-03 | Nxstage Medical, Inc. | Flow-through peritoneal dialysis systems and methods with on-line dialysis solution regeneration |
| US6706287B2 (en) * | 2001-05-15 | 2004-03-16 | Kibow Biotech Inc. | Prebiotic and probiotic compositions and methods for their use in gut-based therapies |
| US20020052571A1 (en) * | 2000-09-13 | 2002-05-02 | Fazio Frank A. | Artificial kidney and methods of using same |
| JP4882054B2 (ja) * | 2000-09-13 | 2012-02-22 | 独立行政法人科学技術振興機構 | 腹膜透析液およびその調製法 |
| US6913590B2 (en) * | 2000-09-22 | 2005-07-05 | Sorenson Development, Inc. | Apparatus and method for peritoneal dialysis |
| ATE457817T1 (de) * | 2000-10-30 | 2010-03-15 | Nephros Inc | Zweistufige filterpatrone |
| US7033498B2 (en) * | 2000-11-28 | 2006-04-25 | Renal Solutions, Inc. | Cartridges useful in cleaning dialysis solutions |
| US6579460B1 (en) * | 2001-03-13 | 2003-06-17 | Uop Llc | Process and composition for removing toxins from bodily fluids |
| US7332330B2 (en) * | 2001-09-11 | 2008-02-19 | Renamed Biologics, Inc. | Device for maintaining vascularization near an implant |
| US7241272B2 (en) | 2001-11-13 | 2007-07-10 | Baxter International Inc. | Method and composition for removing uremic toxins in dialysis processes |
| US7597677B2 (en) * | 2001-11-16 | 2009-10-06 | National Quality Care, Inc. | Wearable ultrafiltration device |
| US7645253B2 (en) * | 2001-11-16 | 2010-01-12 | National Quality Care, Inc. | Wearable ultrafiltration device |
| US7309323B2 (en) * | 2001-11-16 | 2007-12-18 | National Quality Care, Inc. | Wearable continuous renal replacement therapy device |
| US6960179B2 (en) * | 2001-11-16 | 2005-11-01 | National Quality Care, Inc | Wearable continuous renal replacement therapy device |
| US20030114787A1 (en) * | 2001-12-13 | 2003-06-19 | Victor Gura | Wearable peritoneal dialysis system |
| JP4890761B2 (ja) | 2002-07-19 | 2012-03-07 | バクスター・インターナショナル・インコーポレイテッド | 腹膜透析を実施するためのシステムおよび方法 |
| EP1523351B1 (en) * | 2002-07-19 | 2010-01-06 | Baxter International Inc. | System for peritoneal dialysis |
| US7276042B2 (en) * | 2003-01-23 | 2007-10-02 | National Quality Care, Inc. | Low hydraulic resistance cartridge |
| US8029454B2 (en) * | 2003-11-05 | 2011-10-04 | Baxter International Inc. | High convection home hemodialysis/hemofiltration and sorbent system |
| US7198785B2 (en) * | 2003-12-09 | 2007-04-03 | Brown University | Systems and methods related to degradation of uremic toxins |
| WO2005062973A2 (en) | 2003-12-24 | 2005-07-14 | Chemica Technologies, Inc. | Dialysate regeneration system for portable human dialysis |
| US8202248B2 (en) * | 2004-08-18 | 2012-06-19 | Sequana Medical Ag | Dialysis implant and methods of use |
| EP1919550B1 (en) * | 2005-08-05 | 2013-07-03 | Fresenius Medical Care Holdings, Inc. | Dual-channel pump for dialysis use |
| US8409864B2 (en) * | 2006-01-06 | 2013-04-02 | Renal Solutions, Inc. | Ammonia sensor and system for use |
| RU2426561C2 (ru) * | 2006-01-30 | 2011-08-20 | Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния | Способы и устройство для перитонеального диализа |
| US8715221B2 (en) | 2006-03-08 | 2014-05-06 | Fresenius Medical Care Holdings, Inc. | Wearable kidney |
| US8012118B2 (en) * | 2006-03-08 | 2011-09-06 | Fresenius Medical Care Holdings, Inc. | Artificial kidney dialysis system |
-
2006
- 2006-03-08 US US11/371,216 patent/US8715221B2/en active Active
-
2007
- 2007-03-08 CN CN2007800076916A patent/CN101394876B/zh not_active Expired - Fee Related
- 2007-03-08 JP JP2008558369A patent/JP5355098B2/ja not_active Expired - Fee Related
- 2007-03-08 KR KR1020087024651A patent/KR101333775B1/ko not_active Expired - Fee Related
- 2007-03-08 WO PCT/US2007/005779 patent/WO2007103411A2/en not_active Ceased
- 2007-03-08 CA CA2644579A patent/CA2644579C/en not_active Expired - Fee Related
- 2007-03-08 EP EP07752474.2A patent/EP1991289B1/en not_active Not-in-force
- 2007-03-08 AU AU2007223935A patent/AU2007223935B2/en not_active Ceased
-
2010
- 2010-05-17 AU AU2010201964A patent/AU2010201964B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2010201964A1 (en) | 2010-06-03 |
| EP1991289A2 (en) | 2008-11-19 |
| CA2644579A1 (en) | 2007-09-13 |
| AU2007223935B2 (en) | 2010-02-18 |
| WO2007103411A3 (en) | 2007-11-01 |
| KR20080100848A (ko) | 2008-11-19 |
| JP2009528897A (ja) | 2009-08-13 |
| AU2010201964B2 (en) | 2012-05-31 |
| CN101394876A (zh) | 2009-03-25 |
| AU2007223935A1 (en) | 2007-09-13 |
| WO2007103411A2 (en) | 2007-09-13 |
| CA2644579C (en) | 2014-10-28 |
| CN101394876B (zh) | 2012-07-04 |
| US8715221B2 (en) | 2014-05-06 |
| EP1991289B1 (en) | 2015-06-24 |
| KR101333775B1 (ko) | 2013-12-02 |
| US20070213665A1 (en) | 2007-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5355098B2 (ja) | 着用可能な腎臓 | |
| JP5538225B2 (ja) | 人工腎臓透析システム | |
| JP5551709B2 (ja) | 携帯型腹膜透析システム | |
| RU2426561C2 (ru) | Способы и устройство для перитонеального диализа | |
| AU2010292448B2 (en) | Peritoneal dialysis system | |
| JP2019536570A (ja) | 透析デバイスおよび透析システムのための吸着剤 | |
| HK1226342A1 (en) | Cartridges useful in cleaning dialysis solutions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100223 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100223 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120621 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120913 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120921 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121022 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130306 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130605 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130801 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130827 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |